Gold prices edge higher; Fed indepedence fears spur safe haven buying
NEW YORK - Phreesia (NYSE: PHR), a patient intake platform valued at $1.65 billion and currently trading near its InvestingPro Fair Value, and Sesame Workshop announced Thursday a five-year collaboration to deliver health education to parents of young children during medical visits. According to InvestingPro analysis, the company shows strong growth potential, with analysts recently revising earnings expectations upward.
Beginning in October, the initiative will feature Sesame Street characters like Elmo, Cookie Monster and Abby Cadabby in educational content displayed on Phreesia’s digital platform as parents check in for their children’s medical appointments.
The campaigns will target caregivers of children from birth to age 5, focusing on pediatric health topics including routine checkups, vaccinations, preventive screenings, and emotional wellbeing.
"As a pediatrician, I’ve seen firsthand how hard it is to reach parents and caregivers with information that’s relevant, actionable and easy to understand," said Christina Suh, MD, MPH, Director of Clinical Affairs at Phreesia.
David Linetsky, Phreesia’s President of Network Solutions, said the collaboration aims to "turn wait time into a moment of learning and discovery."
Aaron Bisman, Senior Vice President at Sesame Workshop, noted the organization’s commitment to children’s health and wellness, saying they’re "excited to collaborate with Phreesia to bring our purpose-driven storytelling into doctor’s offices."
Phreesia, founded in 2005, reports that it enabled approximately 170 million patient visits in 2024, representing one in seven medical visits across the United States. The company’s impressive market penetration has contributed to its robust revenue growth of 16.29% over the last twelve months, reaching $434.5 million. InvestingPro data reveals the company maintains a strong financial health score, with analysts projecting profitability this year. Get detailed insights and more exclusive ProTips with an InvestingPro subscription.
The collaboration builds on Sesame Workshop’s 55-year history of providing educational content for children. The joint campaigns will leverage Sesame Street’s existing health and wellness content library, combining evidence-based health recommendations with the program’s characters.
According to the press release statement, the initiative aims to make potentially stressful medical visits more comfortable for children and provide families with tools to better communicate with healthcare providers. With the company’s moderate debt levels and strong gross profit margin of 68%, as reported by InvestingPro, Phreesia appears well-positioned to execute this strategic initiative. Access the complete Pro Research Report for comprehensive analysis of PHR and 1,400+ other top stocks.
In other recent news, Phreesia Inc. reported its first-quarter earnings, which exceeded consensus estimates for both revenue and adjusted EBITDA. Piper Sandler maintained its Overweight rating on the company’s stock, raising the adjusted EBITDA forecast for fiscal year 2026 by $4.5 million to a midpoint of $87.5 million. Canaccord Genuity adjusted its price target for Phreesia to $34, down from $35, but maintained a Buy rating, noting a 16% growth rate in the Subscription and services segment. Raymond James reiterated an Outperform rating with a $30 price target, citing modest revenue growth and stronger-than-expected margins. The firm projected an adjusted EBITDA of $236 million and a free cash flow of $212 million for fiscal year 2029. DA Davidson also maintained a Buy rating, expressing optimism about Phreesia’s profit growth despite challenges in the Network Solutions segment. JPMorgan reiterated its Overweight rating, encouraged by Phreesia’s fiscal year 2026 growth prospects. These developments reflect a general confidence among analysts in Phreesia’s financial performance and future potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.